Injections, Subcutaneous
Research News and Information

Saturday, November 21, 2009

Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children.

13 Dec 2009 We investigated the effect of subcutaneous anti-D IgG as platelet enhancing therapy in children with idiopathic thrombocytopenic purpura (ITP). Twenty-three children were treated with subcutaneous anti-D 50 microg/kg. The median platelet count ... Read more...

Interleukin-2 therapy in patients with HIV infection.

13 Oct 2009 BACKGROUND: Used in combination with antiretroviral therapy, subcutaneous recombinant interleukin-2 raises CD4+ cell counts more than does antiretroviral therapy alone. The clinical implication of these increases is not known. METHODS: We conducted ... Read more...

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial.

4 Oct 2009 BACKGROUND: Glatiramer acetate, approved for the treatment of relapsing-remitting multiple sclerosis, reduces relapses and disease activity and burden monitored by MRI. We assessed the efficacy of early treatment with glatiramer acetate in delaying ... Read more...

Latest indexed articles for 'Injections, Subcutaneous'

These are the very latest articles for this heading:

• Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children. 13 Dec 2009
• Images in clinical medicine. Injection-site lipoatrophy. 3 Nov 2009
• Interleukin-2 therapy in patients with HIV infection. 13 Oct 2009
• Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. 11 Oct 2009
• Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. 4 Oct 2009
• Localized amyloidosis at the site of enfuvirtide injection. 4 Oct 2009
• [Allergy vaccination] 3 Oct 2009
• Naloxone, but not flupenthixol, disrupts the development of conditioned ejaculatory preference in the male rat. 29 Sep 2009
• Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant. 29 Sep 2009
• The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model. 29 Sep 2009
• Incidence and causes of heparin-induced skin lesions. 26 Sep 2009
• The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy. 17 Sep 2009
• Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice. 10 Sep 2009
• Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study. 9 Sep 2009
• [Elevation of liver enzymes in a patient with chronic hepatitis B during alpha-interferon treatment: what is it all about?] 8 Sep 2009
• New antithrombotic drugs: potential for use in oncology. 6 Sep 2009
• Calpain inhibition preserves myocardial structure and function following myocardial infarction. 2 Sep 2009
• Short-term effects of parathyroid hormone on rat lumbar vertebrae. 30 Aug 2009
• A systematic review of permanent and semipermanent dermal fillers for HIV-associated facial lipoatrophy. 30 Aug 2009
• Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Injections, Subcutaneous'

Definition: Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin.

Descriptor UI: D007279

Alternative terms: Injections, Subcutaneous; Subcutaneous Injections; Injection, Subcutaneous; Subcutaneous Injection;

Allowable Qualifiers: adverse effects; classification; economics; history; instrumentation; methods; mortality; nursing; psychology; standards; trends; utilization; veterinary; statistics & numerical data; contraindications; ethics;

Tree Number: E02.319.267.530.620;

Technical Notes: NIM; do not use /util except by MeSH definition; DF: INJECT SUBCUTANEOUS